IsoRay, Inc. (NYSEMKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, …
Maxim’s healthcare analyst Jason Kolbert came out today with his views on IsoRay, Inc (NYSEMKT:ISR), after the company released its financial results for the quarter ended June …
IsoRay, Inc. (NYSEMKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it has appointed PCG Advisory Group …
IsoRay, Inc. (NYSEMKT:ISR) , a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced it participated at the American Association …
IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in brachytherapy and medical isotope applications, announced that Dr.
IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced the appointment, on June 18, …
IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced the successful evaluation of its …
IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications; announced it presented last Friday at …
IsoRay, Inc. (NYSE MKT:ISR) has had a very interesting time in the market this week.
IsoRay, Inc. (NYSEMKT:ISR) shares soared as much as 94 percent yesterday, after the company released data in an online publication regarding the first major peer reviewed …